324 related articles for article (PubMed ID: 30192723)
1. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
Milano AF
J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
[TBL] [Abstract][Full Text] [Related]
2. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
3. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.
Aschebrook-Kilfoy B; Ward MH; Sabra MM; Devesa SS
Thyroid; 2011 Feb; 21(2):125-34. PubMed ID: 21186939
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
6. Endocrine gland cancer.
Correa P; Chen VW
Cancer; 1995 Jan; 75(1 Suppl):338-52. PubMed ID: 8001005
[TBL] [Abstract][Full Text] [Related]
7. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Lim H; Devesa SS; Sosa JA; Check D; Kitahara CM
JAMA; 2017 Apr; 317(13):1338-1348. PubMed ID: 28362912
[TBL] [Abstract][Full Text] [Related]
8. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
9. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
Singer RB
J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
[TBL] [Abstract][Full Text] [Related]
10. Pediatric thyroid cancer: An update from the SEER database 2007-2012.
Dermody S; Walls A; Harley EH
Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():121-6. PubMed ID: 27619041
[TBL] [Abstract][Full Text] [Related]
11. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study.
Albores-Saavedra J; Henson DE; Glazer E; Schwartz AM
Endocr Pathol; 2007; 18(1):1-7. PubMed ID: 17652794
[TBL] [Abstract][Full Text] [Related]
12. Follicular thyroid cancer incidence patterns in the United States, 1980-2009.
Aschebrook-Kilfoy B; Grogan RH; Ward MH; Kaplan E; Devesa SS
Thyroid; 2013 Aug; 23(8):1015-21. PubMed ID: 23360496
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Veiga LH; Neta G; Aschebrook-Kilfoy B; Ron E; Devesa SS
Thyroid; 2013 Jun; 23(6):748-57. PubMed ID: 23410185
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
15. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.
Enewold L; Zhu K; Ron E; Marrogi AJ; Stojadinovic A; Peoples GE; Devesa SS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):784-91. PubMed ID: 19240234
[TBL] [Abstract][Full Text] [Related]
16. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
17. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival.
Colonna M; Bossard N; Guizard AV; Remontet L; Grosclaude P;
Ann Endocrinol (Paris); 2010 Mar; 71(2):95-101. PubMed ID: 20036351
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Survival of Thyroid Cancer in Children, Adolescents, and Young Adults in Denmark: A Nationwide Study from 1980 to 2014.
Schmidt Jensen J; Grønhøj C; Mirian C; Jensen DH; Friborg J; Hahn CH; Agander TK; Hjuler T
Thyroid; 2018 Sep; 28(9):1128-1133. PubMed ID: 29943676
[TBL] [Abstract][Full Text] [Related]
19. Trends in thyroid cancer: Retrospective analysis of incidence and survival in Denmark 1980-2014.
Mirian C; Grønhøj C; Jensen DH; Jakobsen KK; Karnov K; Jensen JS; Hahn CH; Klitmøller TA; Bentzen J; von Buchwald C
Cancer Epidemiol; 2018 Aug; 55():81-87. PubMed ID: 29852396
[TBL] [Abstract][Full Text] [Related]
20. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
